Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Zinman

Showing results (111-120 of 217) with videos related to

Pageof 22
Sort By:
The American Journal of Physiology|May 1, 1982
Metabolic response of normal man and insulin-infused diabetics to postprandial exerciseJ D Nelson, P Poussier, E B Marliss, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 19, 2006
Use of vascular risk-modifying medications for diabetic patients differs between physician specialtiesB R Shah, J E Hux, A Laupacis, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitusB Zinman, A J Hanley, S B Harris, et al.
Canadian Journal of Physiology and Pharmacology|October 1, 1982
Exercise in diabetic man: glucose turnover and free insulin responses after glycemic normalization with intravenous insulinB Zinman, E B Marliss, A K Hanna, et al.
Clinical Biochemistry|April 22, 1999
Increased plasma apolipoprotein B-containing lipoproteins associated with increased urinary albumin within the microalbuminuria range in type 2 diabetesR A Hegele, S B Harris, B Zinman, et al.
Diabetes Care|November 1, 1996
Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention EvaluationH C Gerstein, J Bosch, J Pogue, et al.
Diabetes Care|March 1, 1983
Open-loop intravenous insulin waveforms for postprandial exercise in type I diabetesP Poussier, B Zinman, E B Marliss, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 22, 2013
Effect of maternal gestational diabetes on the cardiovascular risk factor profile of infants at 1 year of ageR Retnakaran, C Ye, A Hanley, et al.
International Journal of Clinical Practice|October 21, 2005
Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goalS Del Prato, A-M Felton, N Munro, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 28, 2011
The postpartum cardiovascular risk factor profile of women with isolated hyperglycemia at 1-hour on the oral glucose tolerance test in pregnancyR Retnakaran, Y Qi, M Sermer, et al.
Pageof 22

Showing results (111-120 of 217) with videos related to

Sort By:
Pageof 22
The American Journal of Physiology|May 1, 1982
Metabolic response of normal man and insulin-infused diabetics to postprandial exerciseJ D Nelson, P Poussier, E B Marliss, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 19, 2006
Use of vascular risk-modifying medications for diabetic patients differs between physician specialtiesB R Shah, J E Hux, A Laupacis, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitusB Zinman, A J Hanley, S B Harris, et al.
Canadian Journal of Physiology and Pharmacology|October 1, 1982
Exercise in diabetic man: glucose turnover and free insulin responses after glycemic normalization with intravenous insulinB Zinman, E B Marliss, A K Hanna, et al.
Clinical Biochemistry|April 22, 1999
Increased plasma apolipoprotein B-containing lipoproteins associated with increased urinary albumin within the microalbuminuria range in type 2 diabetesR A Hegele, S B Harris, B Zinman, et al.
Diabetes Care|November 1, 1996
Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention EvaluationH C Gerstein, J Bosch, J Pogue, et al.
Diabetes Care|March 1, 1983
Open-loop intravenous insulin waveforms for postprandial exercise in type I diabetesP Poussier, B Zinman, E B Marliss, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 22, 2013
Effect of maternal gestational diabetes on the cardiovascular risk factor profile of infants at 1 year of ageR Retnakaran, C Ye, A Hanley, et al.
International Journal of Clinical Practice|October 21, 2005
Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goalS Del Prato, A-M Felton, N Munro, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 28, 2011
The postpartum cardiovascular risk factor profile of women with isolated hyperglycemia at 1-hour on the oral glucose tolerance test in pregnancyR Retnakaran, Y Qi, M Sermer, et al.
Pageof 22